Skip to main content

Table 5 Treatment assessment distribution of the study group

From: PET/CT vs CECT in assessment of therapeutic response in lymphoma

  Number Percent
CT
 Complete regression 3 15.0
 Progression disease 2 10.0
 Partial regression 15 75.0
 Stationary disease 0 0.0
PET
 Complete regression 12 60.0
 Progression disease 2 10.0
 Partial regression 6 30.0
 Stationary disease 0 0.0